Heidi Borgeraas

841 total citations
19 papers, 601 citations indexed

About

Heidi Borgeraas is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Heidi Borgeraas has authored 19 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Physiology. Recurrent topics in Heidi Borgeraas's work include Bariatric Surgery and Outcomes (9 papers), Diet and metabolism studies (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). Heidi Borgeraas is often cited by papers focused on Bariatric Surgery and Outcomes (9 papers), Diet and metabolism studies (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). Heidi Borgeraas collaborates with scholars based in Norway, United States and United Kingdom. Heidi Borgeraas's co-authors include Jøran Hjelmesæth, Jens Kristoffer Hertel, Line Kristin Johnson, Dag Hofsø, Marius Svanevik, Milada Cvancarova Småstuen, Rune Sandbu, Ottar Nygård, Njord Nordstrand and Hanne L. Gulseth and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Annals of Surgery.

In The Last Decade

Heidi Borgeraas

18 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heidi Borgeraas Norway 11 311 278 167 118 73 19 601
Monika Proczko-Stepaniak Poland 13 136 0.4× 256 0.9× 97 0.6× 37 0.3× 39 0.5× 41 446
Carolina M. Perdomo Spain 10 295 0.9× 141 0.5× 134 0.8× 209 1.8× 88 1.2× 22 691
Lisa J. Young Australia 6 251 0.8× 389 1.4× 46 0.3× 169 1.4× 40 0.5× 7 851
Douglas Twenefour United Kingdom 6 341 1.1× 265 1.0× 82 0.5× 337 2.9× 23 0.3× 8 650
S. B. Doldi Italy 12 329 1.1× 653 2.3× 69 0.4× 110 0.9× 38 0.5× 28 862
Abbie L. Cawood United Kingdom 11 213 0.7× 137 0.5× 35 0.2× 32 0.3× 53 0.7× 16 522
Zohreh Tabassi Iran 13 174 0.6× 177 0.6× 93 0.6× 79 0.7× 36 0.5× 20 820
Thaís Steemburgo Brazil 16 464 1.5× 97 0.3× 157 0.9× 160 1.4× 30 0.4× 43 886
Pierre Bel Lassen France 12 227 0.7× 80 0.3× 111 0.7× 37 0.3× 37 0.5× 30 464
Hermann Harder Germany 13 149 0.5× 175 0.6× 51 0.3× 40 0.3× 26 0.4× 28 516

Countries citing papers authored by Heidi Borgeraas

Since Specialization
Citations

This map shows the geographic impact of Heidi Borgeraas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Borgeraas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Borgeraas more than expected).

Fields of papers citing papers by Heidi Borgeraas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Borgeraas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Borgeraas. The network helps show where Heidi Borgeraas may publish in the future.

Co-authorship network of co-authors of Heidi Borgeraas

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Borgeraas. A scholar is included among the top collaborators of Heidi Borgeraas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Borgeraas. Heidi Borgeraas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Svanevik, Marius, Heidi Borgeraas, Rune Sandbu, et al.. (2023). Patient-reported outcomes, weight loss, and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy (Oseberg); a single-centre, randomised controlled trial. The Lancet Diabetes & Endocrinology. 11(8). 555–566. 30 indexed citations
3.
Young, James B., Kathrine Aglen Seeberg, Kristin M. Aakre, et al.. (2023). The liver-heart axis in patients with severe obesity: The association between liver fibrosis and chronic myocardial injury may be explained by shared risk factors of cardiovascular disease. Clinical Biochemistry. 123. 110688–110688. 1 indexed citations
4.
Berk, Kirsten A., Heidi Borgeraas, Ingunn Narverud, et al.. (2022). Differential effects of bariatric surgery and lifestyle interventions on plasma levels of Lp(a) and fatty acids. Lipids in Health and Disease. 21(1). 145–145. 9 indexed citations
5.
6.
Seeberg, Kathrine Aglen, Dag Hofsø, Heidi Borgeraas, et al.. (2022). Association between hepatic steatosis and fibrosis with measures of insulin sensitivity in patients with severe obesity and type 2 diabetes - a cross-sectional study. BMC Gastroenterology. 22(1). 448–448. 5 indexed citations
7.
8.
Medhus, Asle W., Jens Kristoffer Hertel, Heidi Borgeraas, et al.. (2020). Erosive Esophagitis and Symptoms of Gastroesophageal Reflux Disease in Patients with Morbid Obesity with and without Type 2 Diabetes: a Cross-sectional Study. Obesity Surgery. 30(7). 2667–2675. 7 indexed citations
9.
Borgeraas, Heidi, Dag Hofsø, Jens Kristoffer Hertel, & Jøran Hjelmesæth. (2020). Comparison of the effect of Roux‐en‐Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials. Obesity Reviews. 21(6). e13011–e13011. 73 indexed citations
10.
11.
Hofsø, Dag, Heidi Borgeraas, Kåre I. Birkeland, et al.. (2019). Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial. The Lancet Diabetes & Endocrinology. 7(12). 912–924. 148 indexed citations
12.
Borgeraas, Heidi, et al.. (2018). Association of time of obesity onset with comorbidities in treatment‐seeking men and women with severe obesity. Obesity Science & Practice. 4(5). 427–436. 10 indexed citations
13.
Seip, Birgitte, Jøran Hjelmesæth, Asle W. Medhus, et al.. (2017). Diagnostic accuracy of the GerdQ questionnaire in the assessment of erosive esophagitis in patients preparing for bariatric surgery. Surgery for Obesity and Related Diseases. 13(10). S71–S72. 1 indexed citations
14.
15.
Borgeraas, Heidi, Jens Kristoffer Hertel, Gard Frodahl Tveitevåg Svingen, et al.. (2016). Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris. PLoS ONE. 11(3). e0152029–e0152029. 12 indexed citations
16.
Borgeraas, Heidi, Jens Kristoffer Hertel, Reinhard Seifert, et al.. (2016). Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study. Lipids in Health and Disease. 15(1). 38–38. 11 indexed citations
17.
Borgeraas, Heidi, Jens Kristoffer Hertel, Gard Frodahl Tveitevåg Svingen, et al.. (2014). Association of body mass index with risk of acute myocardial infarction and mortality in Norwegian male and female patients with suspected stable angina pectoris: a prospective cohort study. BMC Cardiovascular Disorders. 14(1). 68–68. 26 indexed citations
18.
Løland, Kjetil Halvorsen, Øyvind Bleie, Heidi Borgeraas, et al.. (2013). The Association between Progression of Atherosclerosis and the Methylated Amino Acids Asymmetric Dimethylarginine and Trimethyllysine. PLoS ONE. 8(5). e64774–e64774. 30 indexed citations
19.
Borgeraas, Heidi, Elin Strand, Eva Ringdal Pedersen, et al.. (2012). Omega-3 Status and the Relationship between Plasma Asymmetric Dimethylarginine and Risk of Myocardial Infarction in Patients with Suspected Coronary Artery Disease. Cardiology Research and Practice. 2012. 1–11. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monika Proczko-Stepaniak Breakdown of academic impact, for papers by Carolina M. Perdomo Breakdown of academic impact, for papers by Lisa J. Young Breakdown of academic impact, for papers by Douglas Twenefour Breakdown of academic impact, for papers by S. B. Doldi Breakdown of academic impact, for papers by Abbie L. Cawood Breakdown of academic impact, for papers by Zohreh Tabassi Breakdown of academic impact, for papers by Thaís Steemburgo Breakdown of academic impact, for papers by Pierre Bel Lassen Breakdown of academic impact, for papers by Hermann Harder
Rankless by CCL
2026